Search

everythinglearnresearchcommunity

for

Search:↓

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

The Wnt/β-catenin pathway helps tissue regeneration but can also cause fibrosis, and drugs that inhibit this pathway may aid in healing skin and heart tissues.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Pegvaliase is recommended for treating adults with phenylketonuria.

Methotrexate reduced the need for steroids in asthma patients without worsening their condition.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

Niosomes are promising for skin drug delivery, offering benefits like improved drug penetration and stability.

Iron deficiency common in women, not always linked to hair loss; more research needed.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Low-dose finasteride may cause lasting sexual dysfunction and suicidal thoughts in young men.

Doctors need to be better prepared to assess and treat obesity in patients.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

EETs can delay seizures by affecting GABA activity, offering potential new treatments for seizures.

Capsaicin cream quickly relieved itching in two patients with brachioradial pruritus.

Platelet-rich plasma, taken from a person's own blood, can help rejuvenate skin, stimulate hair growth, and treat hair loss, but more research is needed to confirm its safety and effectiveness.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

HIV can cause unusual and severe skin problems that are hard to treat.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Artesunate is generally safe for severe malaria, but patients should be monitored for delayed anemia after treatment.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

The document concludes that more research is needed to understand how to treat muscle pain with drugs.

Ice-skating athletes often have skin problems due to cold, infections, and inflammation, needing careful treatment and prevention.

Face-lifts can lead to complications like bleeding, nerve injury, skin death, hair loss, and rare infections, with careful surgery reducing risks.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

CYLD mutations cause a variety of skin tumors with symptoms starting around age 16, and treatments are currently limited.